Vaccination with Single Chain Antigen Receptors for Islet-Derived Peptides Presented on I-Ag7 Delays Diabetes in NOD Mice by Inducing Anergy in Self-Reactive T-Cells

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Gurr, Werner ^a   Shaw, Margaret ^a   Herzog, Raimund I ^a   Li, Yanxia ^a   Sherwin, Robert ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; BDC2.5 VACCINE; EPITOPE; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CLONAL ANERGY; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; IMMUNE RESPONSE; IMMUNOREACTIVITY; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RECEPTOR BINDING; VACCINATION; VACCINE PRODUCTION;

EID: 84880826658     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069464     Document Type: Article

References (46)

1. Yanez R, Barrios Y, Ruiz E, Cabrera R, Diaz-Espada F, (2008) Anti-idiotypic Immunotherapy in follicular lymphoma patients: results of a long follow-up study. J Immunother 31: 310-312.
2. Coscia M, Kwak LW, (2004) Therapeutic idiotype vaccines in B lymphoproliferative diseases. Expert Opin Biol Ther 4: 959-963.
3. Volovitz I, Marmor Y, Mor F, Flugel A, Odoardi F, et al. (2010) T cell vaccination induces the elimination of EAE effector T cells: analysis using GFP-transduced, encephalitogenic T cells. J Autoimmun 35: 135-144.
4. Aroeira LS, (2006) TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis. Clin Immunol 119: 252-260.
5. Hellings N, Raus J, Stinissen P, (2004) T-cell vaccination in multiple sclerosis: update on clinical application and mode of action. Autoimmun Rev 3: 267-275.
6. Achiron A, Mandel M, (2004) T-cell vaccination in multiple sclerosis Autoimmun Rev. 3: 25-32.
7. Zhang J, (2002) T-cell vaccination for autoimmune diseases: immunologic lessons and clinical experience in multiple sclerosis. Expert Rev Vaccines 1: 285-292.
8. Fujii T, Okada M, Fujita Y, Sato T, Tanaka M, Usui T, et al. (2009) Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice. J Autoimmun 33: 125-134.
9. Li ZG, Mu R, Dai ZP, Gao XM, (2005) T cell vaccination in systemic lupus erythematosus with autologous activated T cells. Lupus 14: 884-889.
10. Vandenbark AA, Morgan E, Bartholomew R, Bourdette D, Whitham R, et al. (2001) TCR peptide therapy in human autoimmune diseases. Neurochem Res 26: 713-730.
11. Elias D, Reshef T, Birk OS, van der Zee R, Walker MD, et al. (1991) Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci U S A 88: 3088-3091.
12. Gurr W, Shaw M, Li Y, Sherwin R, (2007) RegII Is a {beta}-Cell Protein and Autoantigen in Diabetes of NOD Mice. Diabetes 56: 34-40.
13. Gurr W, Yavari R, Wen L, Shaw M, Mora C, Christa L, et al. (2002) A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice. Diabetes 51: 339-346.
14. Nikoopour E, Sandrock C, Huszarik K, Krougly O, Lee-Chan E, et al. (2011) Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice. J Immunol 186: 3831-3835.
15. Stadinski BD, Delong T, Reisdorph N, Reisdorph R, Powell RL, et al. (2010) Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 11: 225-231.
16. Krebber A, Bornhauser S, Burmester J, Honegger A, Willuda J, et al. (1997) Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J Immunol Methods 201: 35-55.
17. Arden B, Clark SP, Kabelitz D, Mak TW, (1995) Mouse T-cell receptor variable gene segment families. Immunogenetics 42: 501-530.
18. Silverman GJ, Scott JK, Burton DR, BarbasIII CF (2001) Phage Display A Laboratory Manual. Cold Spring Harbor Laboratory press, ISBN 0-87969-740-7.
19. Kay BK, Winter J, McCaffrey J, editors (1996) Phage-display of Peptides and Proteins. London: Academic Press Inc, ISBN 0-12-402380-0.
20. Roy A, Kucukural A, Zhang Y, (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5: 725-738.
21. Zhang Y, (2007) Template-based modeling and free modeling by I-TASSER in CASP7. Proteins 69Suppl 8: 108-117.
22. Babad J, Geliebter A, DiLorenzo TP, (2010) T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes. Immunology 131: 459-465.
23. Quinn A, Sercarz EE, (1996) T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543). J Autoimmun 9: 365-370.
24. Haskins K, Mcduffie M, (1990) Acceleration of Diabetes in Young Nod Mice with a Cd4+ Islet-Specific T-Cell Clone. Science 249: 1433-1436.
25. Katz JD, Wang B, Haskins K, Benoist C, Mathis D, (1993) Following a Diabetogenic T-Cell from Genesis through Pathogenesis. Cell 74: 1089-1100.
26. Burton AR, Vincent E, Arnold PY, Lennon GP, Smeltzer M, et al. (2008) On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes 57: 1321-1330.
27. Yoshida K, Martin T, Yamamoto K, Dobbs C, Munz C, et al. (2002) Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones. International Immunology 14: 1439-1447.
28. Noy R, Eppel M, Haus-Cohen M, Klechevsky E, Mekler O, et al. (2005) T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy. Expert Rev Anticancer Ther 5: 523-536.
29. Denkberg G, Lev A, Eisenbach L, Benhar I, Reiter Y, (2003) Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen. J Immunol 171: 2197-2207.
30. Denkberg G, Cohen CJ, Lev A, Chames P, Hoogenboom HR, et al. (2002) Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity. Proc Natl Acad Sci U S A 99: 9421-9426.
31. Cohen CJ, Hoffmann N, Farago M, Hoogenboom HR, Eisenbach L, et al. (2002) Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Cancer Res 62: 5835-5844.
32. Krogsgaard M, Wucherpfennig KW, Cannella B, Hansen BE, Svejgaard A, et al. (2000) Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex. J Exp Med 191: 1395-1412.
33. Card KF, Price-Schiavi SA, Liu B, Thomson E, Nieves E, et al. (2004) A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity. Cancer Immunol Immunother 53: 345-357.
34. McMahan RH, Watson L, Meza-Romero R, Burrows GG, Bourdette DN, (2003) Production, characterization, and immunogenicity of a soluble rat single chain T cell receptor specific for an encephalitogenic peptide. J Biol Chem 278: 30961-30970.
35. Epel M, Ellenhorn JD, Diamond DJ, Reiter Y, (2002) A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells. Cancer Immunol Immunother 51: 565-573.
36. Hare BJ, Wyss DF, Osburne MS, Kern PS, Reinherz EL, Wagner G, (1999) Structure, specificity and CDR mobility of a class II restricted single-chain T-cell receptor. Nat Struct Biol 6: 574-581.
37. Weidanz JA, Card KF, Edwards A, Perlstein E, Wong HC, (1998) Display of functional alphabeta single-chain T-cell receptor molecules on the surface of bacteriophage. J Immunol Methods 221: 59-76.
38. Khandekar SS, Bettencourt BM, Wyss DF, Naylor JW, Brauer PP, et al. (1997) Conformational integrity and ligand binding properties of a single chain T-cell receptor expressed in Escherichia coli. J Biol Chem 272: 32190-32197.
39. Novotny J, Ganju RK, Smiley ST, Hussey RE, Luther MA, (1991) A soluble, single-chain T-cell receptor fragment endowed with antigen-combining properties. Proc Natl Acad Sci U S A 88: 8646-8650.
40. Polakova K, Plaksin D, Chung DH, Belyakov IM, Berzofsky JA, et al. (2000) Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity. J Immunol 165: 5703-5712.
41. Stryhn A, Andersen PS, Pedersen LO, Svejgaard A, Holm A, (1996) Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex. Proc Natl Acad Sci U S A 93: 10338-10342.
42. Rognan D, Engberg J, Stryhn A, Andersen PS, Buus S, (2000) Modeling the interactions of a peptide-major histocompatibility class I ligand with its receptors. II. Cross-reaction between a monoclonal antibody and two alpha beta T cell receptors. J Comput Aided Mol Des 14: 71-82.
43. Malby RL, Tulip WR, Harley VR, McKimm-Breschkin JL, Laver WG, et al. (1994) The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody. Structure 2: 733-746.
44. Tomonari K, (1985) T-cell receptor expressed on an autoreactive T-cell clone, clone 4. I. Induction of various T-receptor functions by anti-T idiotypic antibodies. Cell Immunol 96: 147-162.
45. Steenbakkers PG, Boots AM, Rijnders AW, (1999) T-cell anergy induced by clonotype-specific antibodies: modulation of an autoreactive human T-cell clone in vitro. Immunology 96: 586-594.
46. Zhang Y, Skolnick J, (2005) TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res 33: 2302-2309.